Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease.

Date publication

août 2007

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BAUMERT Thomas , Pr MEYER Nicolas

Tous les auteurs :
Schvoerer E, Soulier E, Royer C, Renaudin AC, Thumann C, Fafi-Kremer S, Brignon N, Doridot S, Meyer N, Pinson P, Ellero B, Woehl-Jaegle ML, Meyer C, Wolf P, Zachary P, Baumert T, Stoll-Keller F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/17624837

Résumé

BACKGROUND: End-stage liver disease as a result of chronic hepatitis C virus (HCV) infection is the main indication for liver transplant (LT), but allografts are systematically infected with HCV soon after transplant. Viral quasispecies are poorly described during the early posttransplant period. METHODS: For 17 patients who received an LT for HCV disease, plasma viral quasispecies evolution was determined by sequence analysis of hypervariable region 1 of the E2 envelope gene before transplant (BT), after 7 days (D7), and after 1 month (M1). T helper (Th)1/Th2 cytokine levels were determined concomitantly. RESULTS: HCV quasispecies showed a significant decrease in amino acid diversity at D7 and M1, compared with BT (P

Référence

J Infect Dis. 2007 Aug 15;196(4):528-36